Literature DB >> 19646018

Prevalence and time trend of intestinal metaplasia in Hong Kong.

Yuk Kei Yee1, Ka Wah Wong, Chee Kin Hui, Chi Kuen Chan, Annie O O Chan, Shiu Kam Lam, Fiona M Y Fung, Ivan Hung, Benjamin C Y Wong.   

Abstract

BACKGROUND AND METHODS: Upper endoscopy records from 1998 to 2003 were reviewed. The demographic data, endoscopic diagnosis, results of rapid urease test and the absence or presence of intestinal metaplasia (IM) in histology were reviewed, to evaluate the prevalence of IM and Helicobacter pylori (Hp) infection over time in Hong Kong.
RESULTS: Among 1805 endoscopies performed, 1751 had both rapid urease test and histology available. A significant drop in the prevalence of duodenal ulcers from 17.9% in 1998 to 9.8% in 2003 was found (P = 0.015). Prevalence of IM was 13.9%, 5.9% and 9.4% in Hp positive, Hp negative and overall respectively (P < 0.05). The prevalence of IM increased with age, and the patterns were similar amongst subjects in 1998-2000 and those in 2001-2003. There was progressive decrease in Hp prevalence from 58% in 1998 to 40% in 2001 (P = 0.014), but no further decrease was seen in 2002-3. There was no corresponding decrease in IM prevalence. Instead IM prevalence in 2002-2003 was significantly higher than the prevalence in previous few years (P = 0.04).
CONCLUSION: The prevalence of IM did not change in the period from 1998 to 2003 despite a drop in the prevalence of Hp infection since 1994.

Entities:  

Mesh:

Year:  2009        PMID: 19646018     DOI: 10.1111/j.1440-1746.2009.05799.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  8 in total

1.  Effects of Weipixiao (胃痞消) on Wnt pathway-associated proteins in gastric mucosal epithelial cells from rats with gastric precancerous lesions.

Authors:  Jin-hao Zeng; Hua-feng Pan; You-zhang Liu; Hai-bo Xu; Zi-ming Zhao; Hai-wen Li; Jin-ling Ren; Long-hui Chen; Xia Hu; Yan Yan
Journal:  Chin J Integr Med       Date:  2015-04-14       Impact factor: 1.978

2.  Follow-up of intestinal metaplasia in the stomach: When, how and why.

Authors:  Angelo Zullo; Cesare Hassan; Adriana Romiti; Michela Giusto; Carmine Guerriero; Roberto Lorenzetti; Salvatore Ma Campo; Silverio Tomao
Journal:  World J Gastrointest Oncol       Date:  2012-03-15

Review 3.  Gastric Cancer: an Evolving Disease.

Authors:  Minkyo Song; Charles S Rabkin; M Constanza Camargo
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

4.  The Role of CDX2 in Intestinal Metaplasia Evaluated Using Immunohistochemistry.

Authors:  Byoung Hwan Lee; Nayoung Kim; Hye Seung Lee; Jung Mook Kang; Hyun Kyung Park; Hyun Jun Jo; Cheol Min Shin; Sang Hyub Lee; Young Soo Park; Jin Hyeok Hwang; Jin-Wook Kim; Sook-Hyang Jeong; Dong Ho Lee; Hyun Chae Jung; In Sung Song
Journal:  Gut Liver       Date:  2012-01-12       Impact factor: 4.519

5.  Gastric ulcer patients are more susceptible to developing gastric cancer compared with concomitant gastric and duodenal ulcer patients.

Authors:  Jun-Bo Hong; Wei Zuo; An-Jiang Wang; Shan Xu; Lu-Xia Tu; You-Xiang Chen; Xuan Zhu; Nong-Hua Lu
Journal:  Oncol Lett       Date:  2014-10-02       Impact factor: 2.967

6.  AGA Technical Review on Gastric Intestinal Metaplasia-Epidemiology and Risk Factors.

Authors:  Osama Altayar; Perica Davitkov; Shailja C Shah; Andrew J Gawron; Douglas R Morgan; Kevin Turner; Reem A Mustafa
Journal:  Gastroenterology       Date:  2019-12-06       Impact factor: 22.682

7.  Risk factors for intestinal metaplasia in concomitant gastric and duodenal ulcer disease.

Authors:  Jun-Bo Hong; Liang Xia; Wei Zuo; An-Jiang Wang; Shan Xu; Hui-Fang Xiong; You-Xiang Chen; Xuan Zhu; Nong-Hua Lu
Journal:  Exp Ther Med       Date:  2014-01-28       Impact factor: 2.447

8.  Gastric Intestinal Metaplasia in an Underserved Population in the USA: Prevalence, Epidemiologic and Clinical Features.

Authors:  Tarek Almouradi; Tadd Hiatt; Bashar Attar
Journal:  Gastroenterol Res Pract       Date:  2013-10-22       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.